| abstract |
This invention relates to a use of an effective amount of a BET- family bromodomain inhibitor, or a pharmaceutically acceptable salt thereof, for increasing the level of frataxin, or for increasing the expression of frataxin. This invention also relates to a use of of a BET- family bromodomain inhibitor, or a pharmaceutically acceptable salt thereof, or a composition thereof for treating a condition or a disease associated with decreased levels or activity of frataxin, including Friedreich's ataxia |